Saket Medicare And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.96 M
as on 24-10-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.98 Cr
as on 24-10-2024
- Satisfied Charges ₹ 70.46 Cr
as on 24-10-2024
- Revenue -12.76%
(FY 2023)
- Profit -80.30%
(FY 2023)
- Ebitda -48.46%
(FY 2023)
- Net Worth 11.80%
(FY 2023)
- Total Assets -5.83%
(FY 2023)
About Saket Medicare And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 4.96 M.
The company currently has active open charges totaling ₹18.98 Cr. The company has closed loans amounting to ₹70.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Praveen Manglunia and Sarita Manglunia serve as directors at the Company.
- CIN/LLPIN
U85110RJ2000PTC016168
- Company No.
016168
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Saket Medicare And Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Manglunia  | Director | 01-Mar-2000 | Current |
| Sarita Manglunia | Director | 01-Mar-2000 | Current |
Financial Performance of Saket Medicare And Research Centre.
Saket Medicare And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.76% decrease. The company also saw a substantial fall in profitability, with a 80.3% decrease in profit. The company's net worth Soared by an impressive increase of 11.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saket Medicare And Research Centre?
In 2022, Saket Medicare And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saket Institute Of Medical Science Private LimitedActive 2 years 9 monthsPraveen Manglunia and Sarita Manglunia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jun 2024 | ₹4.24 M | Open |
Sidbi Creation Date: 06 Jun 2024 | ₹4.70 M | Open |
Standard Chartered Bank Creation Date: 28 Apr 2023 | ₹1.52 Cr | Open |
How Many Employees Work at Saket Medicare And Research Centre?
Unlock and access historical data on people associated with Saket Medicare And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saket Medicare And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saket Medicare And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
